Hiroaki Naraba

3.6k total citations · 1 hit paper
41 papers, 3.0k citations indexed

About

Hiroaki Naraba is a scholar working on Molecular Biology, Pharmacology and Genetics. According to data from OpenAlex, Hiroaki Naraba has authored 41 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 14 papers in Pharmacology and 10 papers in Genetics. Recurrent topics in Hiroaki Naraba's work include Inflammatory mediators and NSAID effects (13 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (10 papers) and Estrogen and related hormone effects (8 papers). Hiroaki Naraba is often cited by papers focused on Inflammatory mediators and NSAID effects (13 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (10 papers) and Estrogen and related hormone effects (8 papers). Hiroaki Naraba collaborates with scholars based in Japan and United States. Hiroaki Naraba's co-authors include Sachiko Oh‐ishi, Akinori Ueno, Naoharu Iwai, Ichiro Kudo, Makoto Murakami, Fumiaki Kojima, Yuri Ikeda‐Matsuo, Yoshihito Nakatani, Tomomi Ikeda and Toshihiro Tanioka and has published in prestigious journals such as Journal of Biological Chemistry, Circulation and The Journal of Immunology.

In The Last Decade

Hiroaki Naraba

41 papers receiving 2.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Regulation of Prostaglandin E2 Biosynthesis by Inducible Membrane-associated Prostaglandin E2 Synthase That Acts in Concert with Cyclooxygenase-2

2000 808 citations Makoto Murakami, Hiroaki Naraba et al. Journal of Biological Chemistry profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hiroaki Naraba Japan	23	1.3k	1.2k	740	565	387	41	3.0k
Howard F. Tiano United States	19	2.4k 1.8×	1.1k 0.9×	432 0.6×	1.2k 2.2×	727 1.9×	24	4.1k
Sei‐itsu Murota Japan	33	748 0.6×	1.4k 1.2×	301 0.4×	425 0.8×	418 1.1×	108	3.5k
Charles D. Loftin United States	23	2.0k 1.5×	824 0.7×	284 0.4×	919 1.6×	657 1.7×	37	3.6k
Gen‐ichi Atsumi Japan	20	499 0.4×	1.8k 1.5×	437 0.6×	241 0.4×	256 0.7×	43	3.0k
Dong Ju Son South Korea	36	725 0.5×	1.8k 1.5×	553 0.7×	273 0.5×	102 0.3×	119	4.0k
Yutaka Shoji Japan	26	474 0.4×	1.1k 0.9×	313 0.4×	430 0.8×	331 0.9×	59	2.7k
Mikio Nishizawa Japan	37	350 0.3×	2.1k 1.8×	565 0.8×	239 0.4×	350 0.9×	150	4.3k
Jun‐Yang Liou Taiwan	31	494 0.4×	1.6k 1.4×	321 0.4×	180 0.3×	221 0.6×	68	2.5k
Masako Nakanishi United States	22	481 0.4×	778 0.6×	385 0.5×	276 0.5×	133 0.3×	52	1.9k
Juan Mestre United States	19	782 0.6×	625 0.5×	283 0.4×	398 0.7×	102 0.3×	27	2.0k

Countries citing papers authored by Hiroaki Naraba

Since Specialization

Citations

This map shows the geographic impact of Hiroaki Naraba's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroaki Naraba with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroaki Naraba more than expected).

Fields of papers citing papers by Hiroaki Naraba

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroaki Naraba. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroaki Naraba. The network helps show where Hiroaki Naraba may publish in the future.

Co-authorship network of co-authors of Hiroaki Naraba

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroaki Naraba. A scholar is included among the top collaborators of Hiroaki Naraba based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroaki Naraba. Hiroaki Naraba is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Nakamura, Kazutaka, Hiroaki Naraba, Naoki Kanda, et al.. (2019). Efficacy of belt electrode skeletal muscle electrical stimulation on reducing the rate of muscle volume loss in critically ill patients: A randomized controlled trial. Journal of Rehabilitation Medicine. 51(9). 705–711. 36 indexed citations

Yuhki, Koh-ichi, Fumitaka Ushikubi, Hiroaki Naraba, et al.. (2008). Prostaglandin I2 Plays a Key Role in Zymosan-Induced Mouse Pleurisy. Journal of Pharmacology and Experimental Therapeutics. 325(2). 601–609. 17 indexed citations

Naraba, Hiroaki, et al.. (2007). The intrinsic structure of glucose transporter isoforms Glut1 and Glut3 regulates their differential distribution to detergent‐resistant membrane domains in nonpolarized mammalian cells. FEBS Journal. 274(11). 2843–2853. 10 indexed citations

Kajimoto, Kazuaki, Hiroaki Naraba, & Naoharu Iwai. (2006). MicroRNA and 3T3-L1 pre-adipocyte differentiation. RNA. 12(9). 1626–1632. 196 indexed citations

Kokubo, Yoshihiro, Nozomu Inamoto, Akira Okayama, et al.. (2005). 日本人集団における高血圧とCYBA,CLCNKB,およびKCNMB1の機能的遺伝子多型性の間の関連分析:吹田の研究. Circulation. 69(2). 138–142. 50 indexed citations

Naraba, Hiroaki, Yoshihiro Kokubo, Hitonobu Tomoike, & Naoharu Iwai. (2005). Functional Confirmation of Gitelman's Syndrome Mutations in Japanese. Hypertension Research. 28(10). 805–809. 11 indexed citations

Tago, Naomi, Yoshihiro Kokubo, Nozomu Inamoto, et al.. (2004). A High Prevalence of Gitelman's Syndrome Mutations in Japanese. Hypertension Research. 27(5). 327–331. 47 indexed citations

Yuhki, Koh-ichi, Akinori Ueno, Hiroaki Naraba, et al.. (2004). Prostaglandin Receptors EP2, EP3, and IP Mediate Exudate Formation in Carrageenin-Induced Mouse Pleurisy. Journal of Pharmacology and Experimental Therapeutics. 311(3). 1218–1224. 32 indexed citations

Kojima, Fumiaki, Hiroaki Naraba, Yasuharu Sasaki, et al.. (2003). Prostaglandin E₂ is an enhancer of interleukin‐1β–induced expression of membrane‐associated prostaglandin E synthase in rheumatoid synovial fibroblasts. Arthritis & Rheumatism. 48(10). 2819–2828. 77 indexed citations

10.

Naraba, Hiroaki, Chieko Yokoyama, Naomi Tago, et al.. (2002). Transcriptional Regulation of the Membrane-associated Prostaglandin E2 Synthase Gene. Journal of Biological Chemistry. 277(32). 28601–28608. 128 indexed citations

11.

Ueno, Akinori, Hideki Matsumoto, Hiroaki Naraba, et al.. (2001). Major roles of prostanoid receptors IP and EP3 in endotoxin-induced enhancement of pain perception. Biochemical Pharmacology. 62(2). 157–160. 59 indexed citations

12.

Murakami, Makoto, Hiroaki Naraba, Toshihiro Tanioka, et al.. (2000). Regulation of Prostaglandin E2 Biosynthesis by Inducible Membrane-associated Prostaglandin E2 Synthase That Acts in Concert with Cyclooxygenase-2. Journal of Biological Chemistry. 275(42). 32783–32792. 808 indexed citations breakdown →

13.

Naraba, Hiroaki, et al.. (1999). Examination of signal transduction pathway of stimulated B1 and B2 kinin receptors; MAP kinase pathway to AP-1 translocation in HEK 293 cells. Immunopharmacology. 45(1-3). 35–38. 11 indexed citations

14.

Matsumoto, Hideki, Hiroaki Naraba, Akinori Ueno, et al.. (1998). Induction of cyclooxygenase-2 causes an enhancement of writhing response in mice. European Journal of Pharmacology. 352(1). 47–52. 43 indexed citations

15.

Naraba, Hiroaki, Akinori Ueno, Mineka Yoshimura, et al.. (1998). Agonist stimulation of B₁ and B₂ kinin receptors causes activation of the MAP kinase signaling pathway, resulting in the translocation of AP‐1 in HEK 293 cells. FEBS Letters. 435(1). 96–100. 22 indexed citations

16.

Matsumoto, Hideki, Hiroaki Naraba, Makoto Murakami, et al.. (1997). Concordant Induction of Prostaglandin E2Synthase with Cyclooxygenase-2 Leads to Preferred Production of Prostaglandin E2over Thromboxane and Prostaglandin D2in Lipopolysaccharide-Stimulated Rat Peritoneal Macrophages. Biochemical and Biophysical Research Communications. 230(1). 110–114. 135 indexed citations

17.

Ueno, Akinori, et al.. (1996). The Mediators Involved in Endotoxin-Induced Vascular Permeability Increase in the Rat Skin and Their Interactions. The Japanese Journal of Pharmacology. 70(4). 285–290. 9 indexed citations

18.

Ueno, Akinori, et al.. (1995). Involvement of bradykinin in endotoxin-induced vascular permeability increase in the skin of rats. European Journal of Pharmacology. 284(1-2). 211–214. 10 indexed citations

19.

Naraba, Hiroaki, Yohsuke Imai, Masahiko Hayashi, & Sachiko Oh‐ishi. (1993). Enhanced Production of Platelet-Activating Factor in Stimulated Rat Leukocytes Caused by the Blockade of Lysophospholipid Acylation. The Japanese Journal of Pharmacology. 61(2). 109–113. 7 indexed citations

20.

Hayashi, Masahiko, Yohsuke Imai, Hiroaki Naraba, et al.. (1992). Enhanced production of platelet-activating factor in stimulated rat leukocytes pretreated with triacsin C, a novel acyl-CoA synthetase inhibitor. Biochemical and Biophysical Research Communications. 188(3). 1280–1285. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact